{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:07:30Z","timestamp":1773702450366,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Research Program of the National Institutes of Health (NIH)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The human Poly ADP-ribose Polymerase (PARP) family comprises 17 enzymes responsible for the transfer of ADP-ribose to proteins, forming poly- or mono-ADP-ribosylation. This post-translational modification regulates DNA repair and programmed cell death, processes affecting cancer biology. PARP inhibitors, including the FDA-approved olaparib, are used to treat BRCA-dependent breast and ovarian cancers. Although therapies with use of PARP inhibitors are showing clinical success, their effects on the immune system remain understudied. Prior work has shown that PARP inhibition can modulate inflammatory responses and alter innate immunity. In this study, we evaluated the immunomodulatory effects of olaparib on myeloid cells in vivo, focusing on bone marrow and spleen. Olaparib treatment altered the composition and activation state of dendritic cells, neutrophils, and macrophages. In the bone marrow, olaparib increased the proportion of cDC2 population, mature neutrophils and inflammatory macrophages expressing CD80. In contrast, splenic myeloid cells exhibited enhanced expression of markers associated with tolerogenic phenotypes, including CD206 and CD124 in neutrophils and macrophages. The spleen also showed an increase in immature monocyte-derived dendritic cells (CD206+) and a bias toward the cDC2 subset. These findings indicate that PARP inhibition can induce short-term phenotypic remodeling of myeloid cell populations, promoting a more immunoregulatory profile, especially in the spleen. These changes may contribute to an altered immune landscape with implications for anti-tumor immunity.<\/jats:p>","DOI":"10.3390\/biom15081149","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T08:10:32Z","timestamp":1754899832000},"page":"1149","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PARP Inhibition Shifts Murine Myeloid Cells Toward a More Tolerogenic Profile In Vivo"],"prefix":"10.3390","volume":"15","author":[{"given":"Jose R.","family":"Pittaluga-Villarreal","sequence":"first","affiliation":[{"name":"Functional Cellular Networks Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892-1892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey M.","family":"Daniels","sequence":"additional","affiliation":[{"name":"Functional Cellular Networks Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892-1892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Capece","sequence":"additional","affiliation":[{"name":"Computational Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892-1892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline R.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Functional Cellular Networks Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892-1892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Meier-Schellersheim","sequence":"additional","affiliation":[{"name":"Computational Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892-1892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-605X","authenticated-orcid":false,"given":"Aleksandra","family":"Nita-Lazar","sequence":"additional","affiliation":[{"name":"Functional Cellular Networks Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892-1892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.molcel.2015.06.012","article-title":"The Promise of Proteomics for the Study of ADP-Ribosylation","volume":"58","author":"Daniels","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Faraoni, I., and Graziani, G. (2018). Graziani, Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors. Cancers, 10.","DOI":"10.3390\/cancers10120487"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/bjc.2011.382","article-title":"The role of PARP in DNA repair and its therapeutic exploitation","volume":"105","author":"Javle","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1001\/jama.2015.10795","article-title":"Cancer Immunotherapy Researchers Focus on Refining Checkpoint Blockade Therapies","volume":"314","author":"Jacob","year":"2015","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1158\/1078-0432.CCR-16-3215","article-title":"PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression","volume":"23","author":"Jiao","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(17)30469-2","article-title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): A double-blind, randomised, placebo-controlled, phase 3 trial","volume":"18","author":"Ledermann","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1021\/acs.jproteome.0c00261","article-title":"Dynamic ADP-Ribosylome, Phosphoproteome, and Interactome in LPS-Activated Macrophages","volume":"19","author":"Daniels","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1172\/JCI80006","article-title":"Tumor-induced myeloid deviation: When myeloid-derived suppressor cells meet tumor-associated macrophages","volume":"125","author":"Ugel","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: From mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","article-title":"Macrophages and cancer: From mechanisms to therapeutic implications","volume":"36","author":"Ostuni","year":"2015","journal-title":"Trends Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/his.12407","article-title":"High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma","volume":"65","author":"Pedersen","year":"2014","journal-title":"Histopathology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100029","DOI":"10.1016\/j.xpro.2020.100029","article-title":"Analysis of Myeloid Cells in Mouse Tissues with Flow Cytometry","volume":"1","author":"Liu","year":"2020","journal-title":"STAR Protoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coi.2007.10.010","article-title":"Antigen presentation by monocytes and monocyte-derived cells","volume":"20","author":"Randolph","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Szulc-D\u0105browska, L., Biernacka, Z., Koper, M., Struzik, J., Giery\u0144ska, M., Schollenberger, A., Lasocka, I., and Toka, F.N. (2023). Differential Activation of Splenic cDC1 and cDC2 Cell Subsets following Poxvirus Infection of BALB\/c and C57BL\/6 Mice. Cells, 13.","DOI":"10.3390\/cells13010013"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cvr\/cvw024","article-title":"Temporal neutrophil polarization following myocardial infarction","volume":"110","author":"Ma","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2567.2005.02319.x","article-title":"Ludwig, Monocyte-derived dendritic cells from horses differ from dendritic cells of humans and mice","volume":"117","author":"Mauel","year":"2006","journal-title":"Immunology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1189\/jlb.0512231","article-title":"The mannose receptor","volume":"92","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1084\/jem.20080421","article-title":"Ly6c+ \u201cinflammatory monocytes\u201d are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis","volume":"205","author":"Getts","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.immuni.2021.07.003","article-title":"Resident Cardiac Macrophages Mediate Adaptive Myocardial Remodeling","volume":"54","author":"Wong","year":"2021","journal-title":"Immunity"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.118.314028","article-title":"Tissue Resident CCR2\u2212 and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury","volume":"124","author":"Bajpai","year":"2019","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bertani, F.R., Mozetic, P., Fioramonti, M., Iuliani, M., Ribelli, G., Pantano, F., Santini, D., Tonini, G., Trombetta, M., and Businaro, L. (2017). Classification of M1\/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-08121-8"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Raggi, F., Pelassa, S., Pierobon, D., Penco, F., Gattorno, M., Novelli, F., Eva, A., Varesio, L., Giovarelli, M., and Bosco, M.C. (2017). Regulation of Human Macrophage M1-M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01097"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1016\/S2352-3026(20)30360-4","article-title":"Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: A safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database","volume":"8","author":"Morice","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s43018-020-00148-7","article-title":"Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer","volume":"2","author":"Mehta","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41423-021-00741-5","article-title":"Dendritic cells in cancer immunology","volume":"19","author":"Murphy","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Masucci, M.T., Minopoli, M., and Carriero, M.V. (2019). Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01146"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Saito, Y., Komori, S., Kotani, T., Murata, Y., and Matozaki, T. (2022). The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity. Cancers, 14.","DOI":"10.3390\/cancers14081976"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/jmau.jmau_85_22","article-title":"Dendritic Cell-Based Immunity: Screening of Dendritic Cell Subsets in Breast Cancer-Bearing Mice","volume":"11","author":"Aldahlawi","year":"2023","journal-title":"J. Microsc. Ultrastruct."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1189\/jlb.0112048","article-title":"Monocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cells","volume":"92","author":"Ramos","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity","volume":"4","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Faraoni, I., Consalvo, M.I., Aloisio, F., Fabiani, E., Giansanti, M., Di Cristino, F., Falconi, G., Tentori, L., Di Veroli, A., and Curzi, P. (2019). Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes. Cancers, 11.","DOI":"10.3390\/cancers11091373"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s10735-024-10260-y","article-title":"A key regulator of tumor-associated neutrophils: The CXCR2 chemokine receptor","volume":"55","author":"Kang","year":"2024","journal-title":"J. Mol. Histol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Korbecki, J., Korbecki, J., Kupnicka, P., Chlubek, M., Gor\u0105cy, J., Gutowska, I., and Baranowska-Bosiacka, I. (2022). CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042168"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2016.217","article-title":"TNF\u03b1-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ohms, M., M\u00f6ller, S., and Laskay, T. (2020). An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00532"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mihaila, A.C., Ciortan, L., Macarie, R.D., Vadana, M., Cecoltan, S., Preda, M.B., Hudita, A., Gan, A.M., Jakobsson, G., and Tucureanu, M.M. (2021). Transcriptional Profiling and Functional Analysis of N1\/N2 Neutrophils Reveal an Immunomodulatory Effect of S100A9-Blockade on the Pro-Inflammatory N1 Subpopulation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.708770"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ma, Y. (2021). Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction. Cells, 10.","DOI":"10.3390\/cells10071676"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2147\/JIR.S300679","article-title":"PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis","volume":"14","author":"Wasyluk","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4049\/immunohorizons.2400058","article-title":"Poly(ADP-Ribose) Polymerase-1 Regulates Pyroptosis Independent Function of NLRP3 Inflammasome in Neutrophil Extracellular Trap Formation","volume":"8","author":"Delinois","year":"2024","journal-title":"ImmunoHorizons"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"E415","DOI":"10.1073\/pnas.1211850110","article-title":"Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery","volume":"110","author":"Predina","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"111462","DOI":"10.1016\/j.celrep.2022.111462","article-title":"PARP-inhibition reprograms macrophages toward an anti-tumor phenotype","volume":"41","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"109730","DOI":"10.1016\/j.clim.2023.109730","article-title":"Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individuals","volume":"255","author":"Ravalet","year":"2023","journal-title":"Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-023-00403-2","article-title":"An aging-related immune landscape in the hematopoietic immune system","volume":"21","author":"Lv","year":"2024","journal-title":"Immun. Ageing"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/8\/1149\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:27:01Z","timestamp":1760034421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/8\/1149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["biom15081149"],"URL":"https:\/\/doi.org\/10.3390\/biom15081149","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]}}}